Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson's Breakthroughs

Scroll Top

Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson’s Breakthroughs

Biotech2050

Oct 30, 2024

November 20, 2024

https://www.ddw-online.com/new-vodcast-joanne-taylor-gain-therapeutics-at-neuroscience-2024-32570-202411/

November 19, 2024

https://parkinsonsnewstoday.com/news/gt-02287-safely-enters-brain-early-parkinsons-clinical-trial/

November 13, 2024

https://insights.citeline.com/in-vivo/market-intelligence/the-future-of-inflammation-the-inflammasome-and-beyond-JL3UJUJNGRGGNL2VCEBU2MUWEU/